These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 1739079
1. Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis. Bonnardeaux A, Pichette V, Ouimet D, Geadah D, Habel F, Cardinal J. Am J Kidney Dis; 1992 Jan; 19(1):31-8. PubMed ID: 1739079 [Abstract] [Full Text] [Related]
2. Solute transport in continuous hemodialysis: a new treatment for acute renal failure. Sigler MH, Teehan BP. Kidney Int; 1987 Oct; 32(4):562-71. PubMed ID: 3430952 [Abstract] [Full Text] [Related]
3. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates. Leypoldt JK, Kamerath CD, Gilson JF, Friederichs G. ASAIO J; 2006 Oct; 52(4):404-9. PubMed ID: 16883120 [Abstract] [Full Text] [Related]
5. High dialysate flow rate continuous arteriovenous hemodialysis: a new approach for the treatment of acute renal failure and tumor lysis syndrome. Pichette V, Leblanc M, Bonnardeaux A, Ouimet D, Geadah D, Cardinal J. Am J Kidney Dis; 1994 Apr; 23(4):591-6. PubMed ID: 8154498 [Abstract] [Full Text] [Related]
6. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis. Lindsay RM, Bene B, Goux N, Heidenheim AP, Landgren C, Sternby J. Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690 [Abstract] [Full Text] [Related]
7. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J. Am J Kidney Dis; 1999 Sep; 34(3):486-92. PubMed ID: 10469859 [Abstract] [Full Text] [Related]
8. Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia. Agha-Razii M, Amyot SL, Pichette V, Cardinal J, Ouimet D, Leblanc M. Clin Nephrol; 2000 Jul; 54(1):59-63. PubMed ID: 10939758 [Abstract] [Full Text] [Related]
9. [Continuous arteriovenous hemodialysis in critical patients with acute renal failure]. Chuang FR, Fang JT, Lin JL, Hu SA, Huang CC. J Formos Med Assoc; 1992 Jun; 91 Suppl 2():S156-60. PubMed ID: 1358364 [Abstract] [Full Text] [Related]
10. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Davies SP, Reaveley DA, Brown EA, Kox WJ. Crit Care Med; 1991 Dec; 19(12):1510-5. PubMed ID: 1959370 [Abstract] [Full Text] [Related]
11. Continuous arteriovenous hemodiafiltration: an aggressive approach to the management of acute renal failure. Pattison ME, Lee SM, Ogden DA. Am J Kidney Dis; 1988 Jan; 11(1):43-7. PubMed ID: 3337098 [Abstract] [Full Text] [Related]
12. Comparison of high-efficiency and standard haemodialysis providing equal urea clearances by partial and total dialysate quantification. Mactier RA, Madi AM, Allam BF. Nephrol Dial Transplant; 1997 Jun; 12(6):1182-6. PubMed ID: 9198048 [Abstract] [Full Text] [Related]
14. Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. Lonnemann G, Floege J, Kliem V, Brunkhorst R, Koch KM. Nephrol Dial Transplant; 2000 Aug; 15(8):1189-93. PubMed ID: 10910443 [Abstract] [Full Text] [Related]
15. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations. Lorenzin A, Garzotto F, Alghisi A, Neri M, Galeano D, Aresu S, Pani A, Vidal E, Ricci Z, Murer L, Goldstein SL, Ronco C. Pediatr Nephrol; 2016 Oct; 31(10):1659-65. PubMed ID: 27139897 [Abstract] [Full Text] [Related]